News
The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...
The product, available in 200 mg, 400 mg, 600 mg, and 800 mg strengths, is the generic equivalent of Sumitomo Pharma ...
There are 21 applicants to become the city of New Bedford’s next chief of police. Here's the process of what happens next.
The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.
19h
MiBolsilloColombia on MSNTrump moves to strengthen U.S. drug production with new executive orderTrump has signed a pivotal executive order aimed at revitalizing the U.S. pharmaceutical manufacturing sector. This directive ...
A research team from the University of Oklahoma has pioneered a method that could accelerate drug discovery and reduce ...
Explore cutting-edge methods for detecting alcohol biomarkers and drugs of abuse using alternative sample matrices.
Explore how LC-MS technologies are transforming forensic and clinical toxicology by enabling comprehensive compound detection ...
The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...
Atara Biotherapeutics said a clinical hold on its new drug applications for its Ebvallo tabelecleucel program to treat Epstein-Barr virus by has been lifted by the Food and Drug Administration. The ...
Optimi Health Corp, a manufacturer of GMP-certified MDMA and psilocybin, has received its U.S. FDA Establishment Identifier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results